Ohcanbohtosat

Macrolides for diffuse panbronchiolitis Dahkki Xiufang Lin, Jing Lu, Ming Yang, Bi Rong Dong, Hong Wu

Viečča ollesdeavstta

Role of macrolide therapy in chronic obstructive pulmonary disease Dahkki Fernando J. Martínez, Jeffrey L. Curtis, Richard Albert

Viečča ollesdeavstta Viečča ollesdeavstta

Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis Dahkki Takeaki Hiratsuka

Viečča ollesdeavstta Viečča ollesdeavstta

Mimics in chest disease: interstitial opacities Dahkki Anastasia Oikonomou, Panos Prassopoulos

Viečča ollesdeavstta Viečča ollesdeavstta

The Lung in Inflammatory Bowel Disease† Dahkki Philippe Camus, F Piard, T Ashcroft, Anthony A. Gal, Thomas V. Colby

Viečča ollesdeavstta

Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Dahkki Takeshi Fujii, J Kadota, K Kawakami, Kei Iida, Ryo Shirai, M Kaseda, Sadahiro Kawamoto, S Kohno

Viečča ollesdeavstta Viečča ollesdeavstta

Fourteen-Member Macrolides Promote the Phosphatidylserine Receptor-Dependent Phagocytosis of Apoptotic Neutrophils by Alveolar Macrophages Dahkki Takeshi Yamaryo, Kazunori Oishi, Hiroyuki Yoshimine, Yoshiko Tsuchihashi, Kouji Matsushima, Tsuyoshi Nagatake

Viečča ollesdeavstta

The Role of Macrolides in Noncystic Fibrosis Bronchiectasis Dahkki Bruna de Campos Guimarães e Figueiredo, Cássio da Cunha Ibiapina

Viečča ollesdeavstta Viečča ollesdeavstta

Immunomodulatory Effects of Macrolide Antibiotics – Part 2: Advantages and Disadvantages of Long-Term, Low-Dose Macrolide Therapy Dahkki Josje Altenburg, Casper S. de Graaff, Tjip S. van der Werf, Wim Boersma

Viečča ollesdeavstta

Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications Dahkki Soichiro Kanoh, Bruce K. Rubin

Viečča ollesdeavstta

Small airways diseases: detection and insights with computed tomography Dahkki D.M. Hansell

Viečča ollesdeavstta Viečča ollesdeavstta

Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration Dahkki Heidi Schilter, Adam Collison, Remo Castro Russo, Jonathan S. Foot, Tin T. Yow, Angélica T. Vieira, Lívia D. Tavares, Joërg Mattes, Mauro Martins Teixeira, Wolfgang Jarolimek

Viečča ollesdeavstta Viečča ollesdeavstta

Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappaB transcription factors Dahkki Tohru Kikuchi

Viečča ollesdeavstta

High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia Dahkki Hiroshi Ishii

Viečča ollesdeavstta

Serum Levels of CA19‐9 in patients with nonmalignant respiratory diseases Dahkki Takahide Kodama, Hiroaki Satoh, Hiroichi Ishikawa, Morio Ohtsuka

Viečča ollesdeavstta Viečča ollesdeavstta

Infections Caused by Chlamydophila pneumoniae Dahkki Irena Choroszy−Król, Magdalena Frej−Mądrzak, Hober Martyna, Jolanta Sarowska, Agnieszka Jama−Kmiecik

Viečča ollesdeavstta Viečča ollesdeavstta

Azithromycin Inhibits MUC5AC Production Induced by the<i>Pseudomonas aeruginosa</i>Autoinducer<i>N</i>-(3-Oxododecanoyl) Homoserine Lactone in NCI-H292 Cells Dahkki Yoshifumi Imamura, Katsunori Yanagihara, Yohei Mizuta, Masafumi Seki, Hideaki Ohno, Yasuhito Higashiyama, Yoshitsugu Miyazaki, Kazuhiro Tsukamoto, Yoichi Hirakata, Kazunori Tomono, Jun‐ichi Kadota, Shigeru Kohno

Viečča ollesdeavstta

Erythromycin shortens neutrophil survival by accelerating apoptosis Dahkki Kazutetsu Aoshiba, Atsushi Nagai, K. Konno

Viečča ollesdeavstta

Long-term macrolide maintenance therapy in non-CF bronchiectasis: Evidence and questions Dahkki Charles Haworth, Diana Bilton, J.S. Elborn

Viečča ollesdeavstta Viečča ollesdeavstta

Secretion properties, clearance, and therapy in airway disease Dahkki Bruce K. Rubin

Viečča ollesdeavstta Viečča ollesdeavstta